Sam Brusco, Associate Editor03.21.24
Stryker announced that it has completed the acquisition of France-based joint replacement company SERF SAS.
The deal to acquire SERF SAS was first announced in December 2023.
SEFR SAS has a legacy of over 50 years. The company is recognized worldwide for its innovations in hip implants, which includes the invention of the original Dual Mobility Cup. Stryker said the acquisition complements its existing business in France and across Europe, as well as its global joint replacement portfolio.
The newly acquired SERF SAS allows Stryker to reach a wider range of patients by bolstering its implant product portfolio.
"The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopedic excellence," said Katherine Truppi, President of Stryker's Joint Replacement division. "We welcome the SERF SAS team to Stryker and look forward to working together to help advance product innovation and customer satisfaction."
"The SERF SAS product portfolio is built on a trusted legacy within the orthopedic industry," added Mathieu Badard, VP and GM of Stryker's Joint Replacement division, Europe. "We are thrilled to combine our best-in-class product portfolios and work together to expand our presence within Europe and increase patient access to differentiated products for joint replacement."
The deal to acquire SERF SAS was first announced in December 2023.
SEFR SAS has a legacy of over 50 years. The company is recognized worldwide for its innovations in hip implants, which includes the invention of the original Dual Mobility Cup. Stryker said the acquisition complements its existing business in France and across Europe, as well as its global joint replacement portfolio.
The newly acquired SERF SAS allows Stryker to reach a wider range of patients by bolstering its implant product portfolio.
"The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopedic excellence," said Katherine Truppi, President of Stryker's Joint Replacement division. "We welcome the SERF SAS team to Stryker and look forward to working together to help advance product innovation and customer satisfaction."
"The SERF SAS product portfolio is built on a trusted legacy within the orthopedic industry," added Mathieu Badard, VP and GM of Stryker's Joint Replacement division, Europe. "We are thrilled to combine our best-in-class product portfolios and work together to expand our presence within Europe and increase patient access to differentiated products for joint replacement."